En español

Home › Publications › By Drugs of Abuse › By Stimulants
External link, please review our disclaimer.

Stimulants

NIDA Publications

Sort By: Date | Title
Publication Cover

Prescription and Over-the-Counter Medications (DrugFacts)

Published Jun 2009. Revised May 2012.
Provides an overview of commonly abused prescription drugs—opioids, central nervous system depressants, and stimulants—and explains how they affect the brain, treatments available, and reported use. En Español

Publication Cover

Prescription Drugs: Abuse and Addiction (Research Reports)

Published Jul 2001. Revised Oct 2011.
Examines the non-medical use of prescription drugs-opioids, central nervous system depressants, and stimulants-describing adverse health effects of their use and the prevention and treatment of addiction. En Español

Publication Cover

Cocaine: Abuse and Addiction (Research Reports)

Published May 1999. Revised Sep 2010.
Describes the latest research findings on cocaine, exploring the scope of abuse in the U.S., its potential long- and short-term health effects, maternal cocaine use, and treatment approaches. En Español

Publication Cover

Stimulant ADHD Medications - Methylphenidate and Amphetamines (DrugFacts)

Revised Jun 2009.
Offers basic facts about stimulant ADHD medications—methylphenidate and amphetamines—including their role in the treatment of ADHD, their affect on the brain, and the extent of abuse. En Español

Publication Cover

Cocaine (Mind Over Matter)

Published Jan 1997. Revised Jan 2009.
Explores with young teens how cocaine changes the way nerve cells communicate in the brain and the negative effects the drug can have on the body. En Español

The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. NIH...Turning Discovery Into Health

National Institute on Drug Abuse   |   6001 Executive Boulevard, Room 5213   |   Bethesda, MD 20892-9561

Questions for our staff? E-mail information@nida.nih.gov or call 301-443-1124 (240-221-4007 en español).

Mobile Site